Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Switzerland Equity Preview: Nestle SA, Novartis AG, UBS AG

July 4 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies rose 0.8 percent to 6,237.81. The broader Swiss Performance Index increased 0.8 percent to 5,731.47.

Nestle SA (NESN VX): The world’s largest food company has been holding talks to buy Hsu Fu Chi International Ltd., a Chinese snack and candy maker with a market value of about $2.6 billion, said people familiar with the matter. Nestle gained 0.7 percent to 52.60 francs.

Novartis AG (NOVN VX): The Swiss drugmaker won U.S. approval for a new treatment for a common lung disease tied to smoking. Shares in Novartis gained 0.4 percent to 51.70 francs.

Panalpina Welttransport Holding AG (PWTN SW): The Swiss freight-forwarding company is aiming to boost its market share in air freight and may lag behind market growth in sea cargo, Chief Financial Officer Marco Gadola was quoted as saying in an interview with Finanz und Wirtschaft. Panalpina fell 3.4 percent to 111.60 Swiss francs.

UBS AG (UBSN VX): UBS AG Chairman Kaspar Villiger said the bank isn’t discussing selling its U.S. wealth management business, SonntagsZeitung reported. UBS rose 2.4 percent to 15.69 francs.

To contact the reporter on this story: Klaus Wille in Zurich at kwille@bloomberg.net

To contact the editor responsible for this story: Craig Stirling at cstirling1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.